NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 936 filers reported holding NOVARTIS A G in Q1 2015. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $26,000 | -3.7% | 300 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $27,000 | -6.9% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $29,000 | -43.1% | 300 | -50.0% | 0.00% | -55.6% |
| Q4 2018 | $51,000 | -1.9% | 600 | 0.0% | 0.01% | +12.5% |
| Q3 2018 | $52,000 | +15.6% | 600 | 0.0% | 0.01% | +14.3% |
| Q2 2018 | $45,000 | -95.9% | 600 | -95.7% | 0.01% | -97.4% |
| Q3 2016 | $1,110,000 | +178.9% | 14,056 | +191.3% | 0.27% | +117.5% |
| Q2 2016 | $398,000 | +13.7% | 4,825 | 0.0% | 0.13% | +9.6% |
| Q1 2016 | $350,000 | -62.6% | 4,825 | -55.7% | 0.12% | -61.9% |
| Q4 2015 | $937,000 | -89.7% | 10,885 | -89.0% | 0.30% | -90.3% |
| Q3 2015 | $9,061,000 | -6.5% | 98,580 | -0.0% | 3.11% | +13.5% |
| Q2 2015 | $9,696,000 | -1.4% | 98,593 | +3.7% | 2.74% | -21.4% |
| Q1 2015 | $9,833,000 | +22.4% | 95,046 | +9.7% | 3.48% | +33.6% |
| Q4 2014 | $8,032,000 | – | 86,680 | – | 2.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |